Postoperative outcomes in total hip arthroplasty following femoral head avascular necrosis in HIV-positive patients.
Journal
Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064
Informations de publication
Date de publication:
03 11 2021
03 11 2021
Historique:
received:
09
06
2020
accepted:
20
07
2020
entrez:
5
11
2021
pubmed:
6
11
2021
medline:
12
11
2021
Statut:
epublish
Résumé
Few clinical studies have been published reporting the clinical outcomes of total hip replacement (THA) in HIV-positive patients affected by femoral head avascular necrosis (AVN) often with controversial results and often without any correlation with the immunological patient status. Our study aim is to retrospectively review the outcome of a HIV-positive patient series. 24 THAs perfomed between 2007 and 2017 were assessed in the study. All patients have been classified with Charlson Comorbidity Index (CCI) and the CDC (Center for Disease Control and Prevention) HIV classification. At the latest follow-up each patient have been evaluated using Harris Hip Score (HHS), WOMAC score, a numerical pain rating scale (NRS) and procedure-related complications were collected. At a mean mean follow up of 96,41 months the mean WOMAC score was 91,66 and the mean Harris Hip Score was 86,77 with excellent results in 18 hips, good in 1 and poor in the 5. Post-operative complications were reported in 7 hips, 3 patients developed a periprosthetic joint infection (PJI) in patients with low CD4+ count and history of intravenous drug consumption. We registered a good outcome in HIV patient with femoral head AVN treated with Total Hip replacement. However, we reported a significant increase in complications and revision rate especially referred to PJI, in patient with history of intravenous drug consumption and low CD4+ count. The authors advocate further prospective multicentric studies with larger population in the future. (www.actabiomedica.it).
Sections du résumé
BACKGROUND
Few clinical studies have been published reporting the clinical outcomes of total hip replacement (THA) in HIV-positive patients affected by femoral head avascular necrosis (AVN) often with controversial results and often without any correlation with the immunological patient status. Our study aim is to retrospectively review the outcome of a HIV-positive patient series.
MATERIAL AND METHODS
24 THAs perfomed between 2007 and 2017 were assessed in the study. All patients have been classified with Charlson Comorbidity Index (CCI) and the CDC (Center for Disease Control and Prevention) HIV classification. At the latest follow-up each patient have been evaluated using Harris Hip Score (HHS), WOMAC score, a numerical pain rating scale (NRS) and procedure-related complications were collected.
RESULTS
At a mean mean follow up of 96,41 months the mean WOMAC score was 91,66 and the mean Harris Hip Score was 86,77 with excellent results in 18 hips, good in 1 and poor in the 5. Post-operative complications were reported in 7 hips, 3 patients developed a periprosthetic joint infection (PJI) in patients with low CD4+ count and history of intravenous drug consumption.
CONCLUSION
We registered a good outcome in HIV patient with femoral head AVN treated with Total Hip replacement. However, we reported a significant increase in complications and revision rate especially referred to PJI, in patient with history of intravenous drug consumption and low CD4+ count. The authors advocate further prospective multicentric studies with larger population in the future. (www.actabiomedica.it).
Identifiants
pubmed: 34738592
doi: 10.23750/abm.v92i5.9917
pmc: PMC8689344
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2021296Références
J Bone Joint Surg Am. 2018 May 2;100(9):777-785
pubmed: 29715226
Orthop Res Rev. 2016 Jun 28;8:13-29
pubmed: 30774467
Clin Infect Dis. 2007 Mar 1;44(5):739-48
pubmed: 17278070
Clin Cases Miner Bone Metab. 2015 Jan-Apr;12(Suppl 1):31-8
pubmed: 27134630
Clin Orthop Relat Res. 2012 May;470(5):1507-12
pubmed: 22207561
Int J Antimicrob Agents. 2014 Aug;44(2):93-5
pubmed: 24726526
BMC Musculoskelet Disord. 2017 Jan 9;18(1):8
pubmed: 28068972
J Bone Joint Surg Am. 1969 Jun;51(4):737-55
pubmed: 5783851
Medicine (Baltimore). 2018 Oct;97(40):e12484
pubmed: 30290604
Rev Bras Ortop. 2018 Feb 03;53(6):773-777
pubmed: 30377614
MMWR Recomm Rep. 1992 Dec 18;41(RR-17):1-19
pubmed: 1361652
Iowa Orthop J. 2014;34:102-6
pubmed: 25328467
Orthop Rev (Pavia). 2019 Mar 22;11(1):8020
pubmed: 30996842
J Arthroplasty. 2016 Oct;31(10):2146-51
pubmed: 27131415
Scand J Rheumatol. 2003;32(1):46-51
pubmed: 12635946
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
JAMA. 2016 Jul 12;316(2):191-210
pubmed: 27404187
Clin Orthop Relat Res. 2016 Feb;474(2):357-64
pubmed: 26040966
Rheumatol Int. 2013 Jan;33(1):235-8
pubmed: 21938549
Orthop Traumatol Surg Res. 2016 Dec;102(8):1029-1034
pubmed: 28341264
HIV Med. 2012 Nov;13(10):623-9
pubmed: 22500743
J Arthroplasty. 2014 Feb;29(2):277-82
pubmed: 23867663
Orthop Traumatol Surg Res. 2018 Sep;104(5):671-674
pubmed: 29908354
Chin Med J (Engl). 2015 Aug 5;128(15):2059-64
pubmed: 26228219
Malawi Med J. 2013 Jun;25(2):28-32
pubmed: 24098826